These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9614026)

  • 41. Gastro-oesophageal reflux disease.
    Sifrim D; Lundell L; Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):757-8. PubMed ID: 21126690
    [No Abstract]   [Full Text] [Related]  

  • 42. The diagnosis and management of gastro-oesophageal reflux in infants.
    Vandenplas Y; Salvatore S; Hauser B
    Early Hum Dev; 2005 Dec; 81(12):1011-24. PubMed ID: 16278060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cough and gastro-oesophageal reflux.
    Ing AJ; Ngu MC
    Lancet; 1999 Mar; 353(9157):944-6. PubMed ID: 10459900
    [No Abstract]   [Full Text] [Related]  

  • 44. [Overweight and gastro-oesophageal reflux disease].
    Capello M; Karup AL; Rask P; Pahle E; Nielsen MF
    Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.
    Tighe MP; Afzal NA; Bevan A; Beattie RM
    Paediatr Drugs; 2009; 11(3):185-202. PubMed ID: 19445547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gastroesophageal Reflux Disease].
    Park CH; Lee SK
    Korean J Gastroenterol; 2019 Feb; 73(2):70-76. PubMed ID: 30845382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical management vs. surgery for gastroesophageal reflux disease.
    Kripke C
    Am Fam Physician; 2010 Aug; 82(3):244. PubMed ID: 20672787
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease].
    Rev Gastroenterol Mex; 2007; 72(2):163-76. PubMed ID: 17966380
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroesophageal reflux disease: current treatment approaches.
    Biddle W
    Gastroenterol Nurs; 2003; 26(6):228-36; quiz 236-7. PubMed ID: 14676609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient information. Pediatric reflux: a burp gone bad.
    Adv Nurse Pract; 2004 Jan; 12(1):51. PubMed ID: 14730837
    [No Abstract]   [Full Text] [Related]  

  • 56. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
    Johannson KA; Strâmbu I; Ravaglia C; Grutters JC; Valenzuela C; Mogulkoc N; Luppi F; Richeldi L; Wells AU; Vancheri C; Kreuter M;
    Lancet Respir Med; 2017 Jul; 5(7):591-598. PubMed ID: 28664861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management of patients with GERD. Clinical practice guideline. 2008 update. Clinical Practice Guideline Working Group on GERD].
    Marzo M; Carrillo R; Mascort JJ; Alonso P; Mearin F; Ponce J; Ferrándiz J; Fernández M; Martínez G; Sáez M; Bonfill X; Piqué JM;
    Gastroenterol Hepatol; 2009; 32(6):431-64. PubMed ID: 19757508
    [No Abstract]   [Full Text] [Related]  

  • 60. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies.
    Tran T; Lowry AM; El-Serag HB
    Aliment Pharmacol Ther; 2007 Jan; 25(2):143-53. PubMed ID: 17229239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.